<DOC>
	<DOCNO>NCT00235898</DOCNO>
	<brief_summary>The objective trial compare efficacy safety CoFactor 5-fluorouracil ( 5-FU ) versus leucovorin 5-FU treatment metastatic colorectal cancer .</brief_summary>
	<brief_title>Clinical Trial Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Have surgically incurable , confirm metastatic colon rectal adenocarcinoma . Be male nonpregnant , nonlactating female subject â‰¥ 18 year age . If female , childbearing potential , agree use adequate contraception ( deem investigator ) throughout participation study 30 day discontinuation study medication . If , female childbearing potential , negative pregnancy test prior start study . Have life expectancy least 6 month . Have radiologically clinically measurable disease response assessment . Presence ascites pleural effusion ( ) acceptable single site response assessment , may present dimensional discrete measurable disease present evaluation . Have ECOG Performance Level 02 ( Karnofsky 10070 ) . A low ECOG Karnofsky acceptable clearly due nononcologic condition ( e.g. , prior paraplegia polio ) . Have prior chemotherapy establish , metastatic disease . ( Subjects may receive adjuvant chemotherapy fluoropyrimidine therapy ) . Have least 6 month elapse since prior adjuvant 5FU CPT11 therapy , Mitomycin C nitrosourea therapy . Have least 8 week interval since prior radiation therapy 4 week since major surgery . Have recover toxicity result prior therapy ( except alopecia ) . Adequate renal , bone marrow , liver function define serum creatinine le 1.5 time upper limit normal , serum bilirubin le 2 time upper limit normal , ANC great 1.5 x 109/L , Platelet count great 90 x 109/L , SGOT ( AST ) SGPT ( ALT ) less 3 time upper limit normal . Failure subject subject 's legal representative sign Informed Consent . An inability obtain Informed Consent psychiatric complex medical problem . Have concurrent infection include diagnosis FUO evidence possible central line sepsis ( subject must afebrile start therapy ) . Have unstable oncologic emergency syndrome : superior vena cava ( SVC ) syndrome , rise bilirubin needing stent placement , spinal cord compression , progressive brain metastasis , active bleeding , hypercalcemia , etc . Have unstable medical condition acute coronary syndrome , cardiovascular accident within previous 12 month ( transient ischemic attack , accelerate hypertension ) , etc . Have cerebellar neurologic syndrome Parkinson 's disease , multiple sclerosis , amyotonia . Have know intolerance fluoropyrimidine ( 5FU , Capecitabine , Floxuridine , UFT ) therapy ( dihydropyrimidine dehydrogenase deficiency ) . Patients vomit , diarrhea , nausea grade great 1 . Received investigational drug agent/procedure , i.e . participation another trial within 4 week begin treatment study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>